
|Articles|November 1, 2002
Stockholders to vote: Investments breathe life into ISTA Pharmaceuticals
Irvine, CA-ISTA Pharmaceuticals Inc. has secured $44 million in financing, including a $4 million bridge loan, to complete development work on late-stage ophthalmic products in the company's clinical pipeline.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement